DuPont (NYSE: DD) announced an investment of $175 million to complete the multi-phase expansion of its high-performance DuPont™ Tedlar® PV2001 series oriented film production line. This investment is in addition to $120 million in capacity expansions, announced in August 2009, for raw materials used to make the film, bringing the total commitment of these two phases to $295 million. Tedlar® films serve as the critical component of photovoltaic backsheets, providing long-term durability and performance for photovoltaic modules in all-weather conditions.
Day4 Energy Inc. (TSX: DFE), a leading supplier of high performance, cost-effective solar electric solutions, today announced it has completed the delivery of a turn-key 2.4 megawatt (MW) roof-mounted photovoltaic (PV) power plant for Gunther Heiss Solar Gmbh & Co. KG in Germany. The project was financed by a local Volksbank, backed by Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main.
Energy Conversion Devices, Inc. (ECD) (Nasdaq: ENER), the leading global manufacturer of thin-film flexible solar laminate products for the building integrated and commercial rooftop markets, today announced plans to establish a 30MW solar laminate manufacturing facility in France. The company has started its initial site selection process and is evaluating various sites, particularly in the Alsace region.
Yingli Green Energy Holding Company Limited (NYSE: YGE) ("Yingli Green Energy" or the "Company"), one of the world's leading vertically integrated photovoltaic ("PV") product manufacturers, today announced the Ministry of Science and Technology of China has approved the application to establish the first national-level key laboratory in the field of PV technology development, the State Key Laboratory of PV Technology (the "Laboratory"), at Yingli Green Energy's manufacturing base in Baoding.
MiaSole, a leader in the manufacture of CIGS thin-film photovoltaic modules, has received two Advanced Energy Manufacturing Tax Credits totaling USD 101.8 million from the Obama Administration for the manufacture of Solar PV Cells and modules based on an innovative thin-film production technology. These Solar PV Cells will lower the costs of renewable clean electricity generation.
Suntech Power Holdings Co., Ltd. (NYSE: STP), the world's largest crystalline silicon photovoltaic (PV) module manufacturer, today announced the completion and grid connection of two solar systems on the China Pavilion and the Theme Pavilion of the 2010 Shanghai World Expo.
Novellus Systems (Nasdaq: NVLS) today introduced its next-generation ultra-violet thermal processing (UVTP) system, the SOLA xT. The SOLA xT is used in the manufacturing of advanced logic devices at 45nm and below and incorporates a proprietary UVTP treatment process that modifies the physical characteristics of a previously-deposited film through exposure to ultraviolet light and heat. The new system, featuring on-board UV monitoring and a customizable optics assembly, provides process flexibility and extendibility over multiple device generations. The first SOLA xT system will be shipped to UMC's Fab 12i in Singapore.
Solar companies at every step of the global PV supply chain must begin to focus resources on developing the end-markets that will support the industry in the event of another major market saturation, according to the recently released market report by PHOTON Consulting, Solar Power Markets: Prepare for Impact.
SwissINSO Holding Inc. (OTCBB: SWHN) is pleased to announce the launch of its unique solar solution to the growing problem of drinking water shortages around the world. Powered by solar energy, the water purification units capitalize on cost-effective and cutting-edge patented technologies.
ONTILITY has enhanced its ONTraining Division with both new and updated Solar Training and EcoTraining curricula as well as new, modular solar training classes and NABCEP™ Certified PV Installer and Entry Level Exam Preparatory classes.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.